CPT code 92235 represents fluorescein angiography with multiframe timing and physician interpretation — a diagnostic imaging study that visualizes retinal and choroidal circulation using intravenous fluorescein dye. This test is widely used in ophthalmology to diagnose and manage retinal vascular diseases, macular degeneration, ocular tumors, and to plan some laser treatments. Nationally, the code matters because it defines coverage, reimbursement pathways, and documentation expectations for a commonly performed specialty imaging procedure.

Key payers in the national discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and prior-authorization requirements vary by payer, affecting where and how frequently the procedure is delivered and billed. Reimbursement rates and coding guidance from these payers influence ophthalmology practice patterns and facility billing across outpatient settings.

Readers will learn the clinical context for 92235, the typical service setting, and which major payers commonly cover the study. The publication also summarizes benchmarking and policy topics readers can expect, such as national reimbursement considerations, documentation standards for image interpretation and reporting, and payer-specific coverage nuances where publicly available. Data not available in the input will be clearly flagged in detailed sections.